Tirzepatide (pre-filed pen) 10 mg – US Stock

Tirzepatide 10 mg Pre-Filled Pen – US Stock
Tirzepatide 10 mg is a pre-filled injection pen containing tirzepatide as the active ingredient. Hilma Biocare classifies tirzepatide as a peptide hormone and identifies the product as a 3 mL injection pen with a stated active half-life of approximately 5 days, or 117–120 hours.
Product Overview
Tirzepatide is a synthetic peptide that acts as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The supplied information describes tirzepatide as a linear polypeptide consisting of 39 amino acids that has been chemically modified by lipidation.
The source material describes tirzepatide in the context of glycemic control and weight management and explains its activity through both GIP and GLP-1 receptor pathways.
Product Specifications

Specification
Details

Brand
Hilma Biocare

Active Ingredient
Tirzepatide

Product Group
Peptide Hormone

Subgroup
Injection

Strength
10 mg

Product Form
Pre-filled injection pen

Pack / Pen Volume
3 mL

Active Half-Life
Approximately 117–120 hours

Aromatization
No

Water Retention
Not recognized

US Availability
US Stock

Product Characteristics
Tirzepatide acts on both GIP and GLP-1 receptors, distinguishing it from compounds that selectively target only one of these pathways. According to the supplied information, tirzepatide has a higher affinity for GIP receptors while also activating GLP-1 receptors.
The source describes GIP as a naturally occurring hormone involved in insulin release and explains that tirzepatide’s dual receptor activity influences signaling pathways associated with glucose and lipid metabolism.
The supplied product information also reports an increase in adiponectin and adipokine levels, with a stated maximum increase of 26% from baseline after 26 weeks at a 10 mg dose. This information is reproduced as a factual description from the provided source and is not presented as a guaranteed clinical outcome.
Tirzepatide Formulation
The product is presented as a 10 mg pre-filled injection pen with a stated volume of 3 mL. The supplied specifications identify tirzepatide as the active compound and classify the formulation under peptide hormones.
The reported active half-life is approximately 5 days, corresponding to approximately 117–120 hours.
About Hilma Biocare USA
Tirzepatide 10 mg Pre-Filled Pen is presented as part of the Hilma Biocare product range. This listing identifies the product as US Stock and provides the available factual information concerning its active ingredient, strength, dosage form, packaging, and stated half-life.
Important Information
Tirzepatide is a medically active peptide compound. This page is provided for factual product information and does not constitute personalized medical advice, dosing recommendations, injection instructions, or a treatment protocol. Any consideration of tirzepatide should be discussed with an appropriately qualified healthcare professional.